Astrazeneca Pharma India Ltd (ASTRAZEN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Astrazeneca Pharma India Ltd (ASTRAZEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3385
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas of cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neuroscience, and gastrointestinal. Its cardiovascular and metabolic disease products include candesartan cilexetil, ticagrwlor, exenatide, rosuvastatin, felodipine, metoprolo succinate, pramlintide acetate, and atenolol, among others. AstraZeneca offers oncology products such as anastrozole tablets, tamoxifen tablets, gefitinib tablets, goserelin acetate injection, goserelin acetate depot injection, bicalutamide tablets, and fulvestrant injection. The company operates in China, Hong Kong, India, Singapore, Thailand, Canada, Chile, Colombia, Mexico, the US, and Mauritius, among others. AstraZeneca is headquartered in Bangalore, Karnataka, India.

Astrazeneca Pharma India Ltd (ASTRAZEN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sun Pharma Enters into Co-Marketing Agreement with AstraZenceca Pharma for Dapagliflozin 10
Sun Pharma Enters into Distribution Agreement with Astrazeneca Pharma 11
Dr Reddy’s Labs Enters into Distribution Agreement with Astrazeneca Pharma 12
Asset Transactions 13
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 13
Acquisition 14
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 14
Astrazeneca Pharma India Ltd – Key Competitors 15
Astrazeneca Pharma India Ltd – Key Employees 16
Astrazeneca Pharma India Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
May 09, 2017: AstraZeneca Pharma India Reports Total Income From Operations Of INR5.4 Billion In Fiscal 2017 18
Corporate Communications 19
Aug 08, 2017: AstraZeneca Appoints Mr. Ian John Parish to its Board of Director 19
Jun 29, 2017: AstraZeneca Announces Board Change 20
Other Significant Developments 21
May 17, 2018: AstraZeneca strengthens innovation partnership in India 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sun Pharma Enters into Co-Marketing Agreement with AstraZenceca Pharma for Dapagliflozin 10
Sun Pharma Enters into Distribution Agreement with Astrazeneca Pharma 11
Dr Reddy's Labs Enters into Distribution Agreement with Astrazeneca Pharma 12
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 13
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 14
Astrazeneca Pharma India Ltd, Key Competitors 15
Astrazeneca Pharma India Ltd, Key Employees 16

List of Figures
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Astrazeneca Pharma India Ltd (ASTRAZEN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Electro Scientific Industries Inc (ESIO):企業の財務・戦略的SWOT分析
    Summary Electro Scientific Industries Inc (ESI) is a technology company that offers laser-based manufacturing solutions. The company offers products such as flex interconnect, circuit packaging, high density interconnect, automation, scribbing and grooving, memory repair, wafer marking, laser ablati …
  • Ngai Hing Hong Co Ltd (1047)
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Daicel Corporation (4202):企業の財務・戦略的SWOT分析
    Daicel Corporation (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bausch & Lomb Inc:企業の戦略的SWOT分析
    Bausch & Lomb Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Sumitomo Metal Mining Co Ltd:戦略・SWOT・企業財務分析
    Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • WorleyParsons Ltd (WOR):電力:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …
  • Pfizer Inc (PFE):医療機器:M&Aディール及び事業提携情報
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sensus Healthcare Inc (SRTS):製品パイプライン分析
    Summary Sensus Healthcare Inc (Sensus), previously Sensus Healthcare LLC, designs, manufactures, and markets proprietary medical devices for the treatment of various types of cancers and skin diseases. The company offers superficial radiation therapy (SRT) technology based non-surgical treatment opt …
  • Airbus SE.:企業の戦略・SWOT・財務分析
    Airbus SE. - Strategy, SWOT and Corporate Finance Report Summary Airbus SE. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hofseth Biocare ASA:企業の戦略・SWOT・財務情報
    Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report Summary Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Exactech Inc (EXAC):企業の財務・戦略的SWOT分析
    Summary Exactech Inc (Exactech) is a medical device company that offers orthopedic implant devices and related surgical instruments. The company’s products comprise hip implants, shoulder implants, knee implants, extremity implants, biologics and spine, and other products. It also provides biologic …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • BENEO GmbH:戦略・SWOT・企業財務分析
    BENEO GmbH - Strategy, SWOT and Corporate Finance Report Summary BENEO GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • China Power Clean Energy Development Co Ltd (735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Probe Scientific Ltd-医療機器分野:企業M&A・提携分析
    Summary Probe Scientific Ltd (Probe Scientific) is a medical device company that develops products to solve clinical issues. The company offers products, which include microeye, continumon and nanoeye, among others. Its microeye is a sampling device for monitoring substances such as electrolytes, am …
  • Swiss International Air Lines Ltd.:企業の戦略・SWOT・財務情報
    Swiss International Air Lines Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swiss International Air Lines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Bank Of Ningbo Co. Ltd.
    Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kaefer Isoliertechnik GmbH & Co KG:企業の戦略・SWOT・財務情報
    Kaefer Isoliertechnik GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary Kaefer Isoliertechnik GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Patterson Companies Inc (PDCO):医療機器:M&Aディール及び事業提携情報
    Summary Patterson Companies, Inc. (Patterson) is a distributor of dental and veterinary products, services and technologies. It provides products to the production and companion animal health markets. The company’s product portfolio comprises restorative materials, hand instruments, sterilization pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆